{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:36:49Z","timestamp":1791279409909,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.metabol.2014.10.026","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T01:04:04Z","timestamp":1414631044000},"page":"S11-S15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"S1","title":["Biomarkers of psychiatric diseases: Current status and future prospects"],"prefix":"10.1016","volume":"64","author":[{"given":"Madhu","family":"Kalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Costa e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.10.026_bb0005","first-page":"146","article-title":"Uber eigneartige Erkankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg Zeitschr Psychiatr"},{"key":"10.1016\/j.metabol.2014.10.026_bb0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02866241","article-title":"Uner eignearte Krankenheitsfalle des spatern Alters","volume":"4","author":"Alzheimer","year":"1911","journal-title":"Zeitschr Ges Neur Psych"},{"key":"10.1016\/j.metabol.2014.10.026_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.1999.tb00221.x","article-title":"No man alone: the rediscovery of Alois Alzheimer's original cases","volume":"9","author":"Graeber","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.metabol.2014.10.026_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00019442-200211000-00004","article-title":"Biomarkers in psychiatry. Methodological issues","volume":"10","author":"Kraemer","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0306-4530(87)90076-X","article-title":"The methodological and statistical evaluation of medical tests: the dexamethasone suppression test in psychiatry","volume":"12","author":"Kraemer","year":"1987","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14737159.8.2.209","article-title":"Cerebrospinal fluid: identification of diagnostic markers for schizophrenia","volume":"8","author":"Schwartz","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.metabol.2014.10.026_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definition Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.metabol.2014.10.026_bb0040","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1582-4934.2012.01543.x","article-title":"Potential biomarkers in psychiatry: focus on the cholesterol system","volume":"16","author":"Woods","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0004867414521720","article-title":"ICD future","volume":"48","author":"Malhi","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrn3621","article-title":"DSN-5 and RDoC: progress in psychiatry research","volume":"14","author":"Casey","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.metabol.2014.10.026_bb0055","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1176\/appi.ajp.2011.11020219","article-title":"Neuroscience, clinical evidence, and the future of psychiatry classification in DSM-5","volume":"168","author":"Kupfer","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0060","series-title":"DSM-5","year":"2013"},{"key":"10.1016\/j.metabol.2014.10.026_bb0065","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jpsychires.2013.07.021","article-title":"Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters","volume":"47","author":"Maccarrone","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.metabol.2014.10.026_bb0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.pra.0000413277.11091.25","article-title":"How biomarkers will change psychiatry: from clinical trials to practice. Part I, Introduction","volume":"18","author":"Macaluso","year":"2012","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.metabol.2014.10.026_bb0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/npp.2011.285","article-title":"Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology","volume":"37","author":"Dietzen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.metabol.2014.10.026_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroscience.2009.03.080","article-title":"The genetics of bipolar disorder","volume":"164","author":"Barnett","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.metabol.2014.10.026_bb0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/7854_2010_41","article-title":"Molecules, signaling and schizophrenia","volume":"4","author":"Kvajo","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.metabol.2014.10.026_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1176\/appi.ajp.2010.10070948","article-title":"Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder","volume":"168L","author":"Poelmans","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0100","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/npp.2011.98","article-title":"Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD","volume":"36","author":"Weber","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.metabol.2014.10.026_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1013242910574","article-title":"Proteomic approach for the elucidation of biological defects in autism","volume":"31","author":"Junaid","year":"2001","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.metabol.2014.10.026_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22224","article-title":"Developing biomarkers in mood disorders research through the use of rapidly-acting antidepressants","volume":"31","author":"Niciu","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.metabol.2014.10.026_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress and depression in 73,131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.metabol.2014.10.026_bb0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo depression","volume":"197","author":"Pasko","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"8","key":"10.1016\/j.metabol.2014.10.026_bb0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.biopsych.2006.02.016","article-title":"The association between C-reactive protein levels and depression results from northern Finland 1966 birth cohort study","volume":"60","author":"Liukkonen","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.metabol.2014.10.026_bb0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.metabol.2014.10.026_bb0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.metabol.2014.10.026_bb0145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations with C-reactive protein, IL-1 and IL-6: a meta-analysis","volume":"71","author":"Howgren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.metabol.2014.10.026_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2013.05.019","article-title":"Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels in relation to iron metabolism and the erythron in depression","volume":"63C","author":"Rybka","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0160","first-page":"372","article-title":"The association between serum levels of neopterin and number of depressive episodes of major depression","volume":"34","author":"Celik","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.metabol.2014.10.026_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(94)90003-5","article-title":"Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response","volume":"54","author":"Maes","year":"1994","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.metabol.2014.10.026_bb0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000336803","article-title":"Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome and depression: Inflammatory markers are higher in myalgic encephalomyelitis\/chronic fatigue syndrome than in depression","volume":"81","author":"Maes","year":"2012","journal-title":"Psychother Psychosom"},{"issue":"5","key":"10.1016\/j.metabol.2014.10.026_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0447.2012.01908.x","article-title":"In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes","volume":"127","author":"Maes","year":"2013","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.metabol.2014.10.026_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","article-title":"Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression","volume":"36","author":"Maes","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.metabol.2014.10.026_bb0185","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cardfail.2011.05.004","article-title":"Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study","volume":"17","author":"Michalakeas","year":"2011","journal-title":"J Card Fail"},{"issue":"2\u20133","key":"10.1016\/j.metabol.2014.10.026_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psychres.2012.10.018","article-title":"Increased oxidative stress in patients with depression and its relationship to treatment","volume":"206","author":"Chung","year":"2013","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.metabol.2014.10.026_bb0195","doi-asserted-by":"crossref","first-page":"e65406","DOI":"10.1371\/journal.pone.0065406","article-title":"Lipid peroxidation and depressed mood in community-dwelling older men and women","volume":"8","author":"Milaneschi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.10.026_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.028","article-title":"Epigenetics and depression: return of the repressed","volume":"155","author":"Dalton","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.metabol.2014.10.026_bb0205","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ajmg.b.31109","article-title":"Maternal smoking during pregnancy is associated with epigenetic modifications of brain-derived neurotrophic factor-6 exon in adolescent offspring","volume":"153B","author":"Toledo-Roderiquez","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.metabol.2014.10.026_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/epi.3.2.6034","article-title":"Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid exposure gene (NR3C1) and infant cortisol stress responses","volume":"3","author":"Oberlander","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.metabol.2014.10.026_bb0215","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/tp.2011.21","article-title":"Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor","volume":"1","author":"Radtke","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0220","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4161\/epi.21180","article-title":"Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and new born birth weight","volume":"7","author":"Mulligan","year":"2012","journal-title":"Epigenetics"},{"issue":"8","key":"10.1016\/j.metabol.2014.10.026_bb0225","doi-asserted-by":"crossref","first-page":"e12201","DOI":"10.1371\/journal.pone.0012201","article-title":"Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth","volume":"5","author":"Devlin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.10.026_bb0230","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(00)00950-1","article-title":"Dysfunction of neural circuits involved in the pathophysiology of mood disorders. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells","volume":"48","author":"Rajkowska","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0235","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/13894501113149990014","article-title":"Serum S100B represents a new biomarker for mood disorders","volume":"14","author":"Schroeter","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.metabol.2014.10.026_bb0240","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/sj.npp.1300982","article-title":"Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment","volume":"31","author":"Czeh","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"425","key":"10.1016\/j.metabol.2014.10.026_bb0245","first-page":"1","article-title":"Toward clinically applicable biomarkers in bipolar disorders: focus on BDNF, inflammatory markers and endothelial function","volume":"15","author":"Goldstein","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.metabol.2014.10.026_bb0250","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.2174\/13816128113199990554","article-title":"Endophenotyypes and biological markers of schizophrenia: from biological signs of illness to novel treatment targets","volume":"19","author":"Ferrarelli","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2014.10.026_bb0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.physbeh.2014.02.032","article-title":"Peripheral interleukin\u20132 level is associated with negative symptoms and cognitive performance in schizophrenia","volume":"129","author":"Asevedo","year":"2014","journal-title":"Physiol Behav"},{"key":"10.1016\/j.metabol.2014.10.026_bb0260","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/mp.2013.95","article-title":"Discovery and validation of blood biomarkers for suicidality","volume":"18","author":"Le-Niculescu","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/mp.2008.11","article-title":"Identifying blood biomarkers for mood disorders using convergent functional genomics","volume":"14","author":"Le-Niculescu","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mp.2009.117","article-title":"Identification of blood biomarkers for psychosis using convergent functional genomics","volume":"16","author":"Kurian","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.026_bb0275","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11920-013-0424-x","article-title":"Predicting suicidal behavior: are we really that far along? Comment on \u201cDiscovery and validation of blood biomarkers for suicidality\u201d","volume":"15","author":"Blasco-Fontecilla","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"9","key":"10.1016\/j.metabol.2014.10.026_bb0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/460202a","article-title":"Biomarkers in psychiatry","volume":"460","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.026_bb0285","first-page":"2002","article-title":"Biomarkers for the development of new medications for cocaine dependence","volume":"39","author":"Bough","year":"2014","journal-title":"Neurosychopharmacology Rev"},{"key":"10.1016\/j.metabol.2014.10.026_bb0290","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.biopsych.2012.11.031","article-title":"Human biomarkers of rapid antidepressant effects","volume":"73","author":"Zarate","year":"2013","journal-title":"Biol Psychiatry"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:05:38Z","timestamp":1758427538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514003357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0026049514003357"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.026","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of psychiatric diseases: Current status and future prospects","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}